Research ExplorerScientific StaffFrancis Ayuketang Ayuk Publications

PD Dr. med. ID: 49552

Francis Ayuketang Ayuk

graph of relations
Affiliations
51 - 100 out of 203Page size: 50
Sort by: Title

Publications

  1. Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission

    Klyuchnikov, E., Badbaran, A., Massoud, R., Fritzsche-Friedland, U., Freiberger, P., Ayuk, F., Wolschke, C., Bacher, U. & Kröger, N., 07.2022, In: TRANSPL CELL THER. 28, 7, p. 374.e1-374.e9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  2. Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study.

    Wolschke, C., Stübig, T., Hegenbart, U., Schönland, S., Heinzelmann, M., Hildebrandt, Y., Ayuketang Ayuk, F., Atanackovic, D., Dreger, P., Zander, A. & Kröger, N., 2013, In: EXP HEMATOL. 41, 2, p. 133-134 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms

    Fu, Y., Schroeder, T., Zabelina, T., Badbaran, A., Bacher, U., Kobbe, G., Ayuketang, F. A., Wolschke, C., Schnittger, S., Kohlmann, A., Haferlach, T. & Kröger, N., 01.03.2014, In: EUR J HAEMATOL. 92, 3, p. 189-94 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

    Spanjaart, A. M., Ljungman, P., de La Camara, R., Tridello, G., Ortiz-Maldonado, V., Urbano-Ispizua, A., Barba, P., Kwon, M., Caballero, D., Sesques, P., Bachy, E., Di Blasi, R., Thieblemont, C., Calkoen, F., Mutsaers, P., Maertens, J., Giannoni, L., Nicholson, E., Collin, M., Vaz, C. P., Metafuni, E., Martinez-Lopez, J., Dignan, F. L., Ribera, J-M., Nagler, A., Folber, F., Sanderson, R., Bloor, A., Ciceri, F., Knelange, N., Ayuk, F., Kroger, N., Kersten, M. J. & Mielke, S., 12.2021, In: LEUKEMIA. 35, 12, p. 3585-3588 4 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  5. Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation.

    Cavattoni, I., Zabelina, T., Ayuketang Ayuk, F., Wolschke, C., Bacher, U., Zander, A. R. & Kröger, N., 2010, In: LEUKEMIA LYMPHOMA. 51, 1, p. 146-148 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

    Al Malki, M. M., London, K., Baez, J., Akahoshi, Y., Hogan, W. J., Etra, A., Choe, H., Hexner, E., Langston, A., Abhyankar, S., Ponce, D. M., DeFilipp, Z., Kitko, C. L., Adekola, K., Reshef, R., Ayuk, F., Capellini, A., Chanswangphuwana, C., Eder, M., Eng, G., Gandhi, I., Grupp, S., Gleich, S., Holler, E., Javorniczky, N. R., Kasikis, S., Kowalyk, S., Morales, G., Özbek, U., Rösler, W., Spyrou, N., Yanik, G., Young, R., Chen, Y-B., Nakamura, R., Ferrara, J. L. M. & Levine, J. E., 12.09.2023, In: BLOOD ADV. 7, 17, p. 5189-5198 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR

    Klyuchnikov, E., Badbaran, A., Massoud, R., Freiberger, P., Wolschke, C., Ayuk, F., Fehse, B., Bacher, U. & Kröger, N., 02.2024, In: LEUKEMIA. 38, 2, p. 386-388 3 p.

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  8. Peritransplantation Ruxolitinib Prevents Acute Graft-versus-Host Disease in Patients with Myelofibrosis Undergoing Allogenic Stem Cell Transplantation

    Kröger, N., Shahnaz Syed Abd Kadir, S., Zabelina, T., Badbaran, A., Christopeit, M., Ayuk, F. & Wolschke, C., 10.2018, In: BIOL BLOOD MARROW TR. 24, 10, p. 2152-2156 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.

    Ocheni, S., Zabelina, T., Bacher, U., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 2009, In: LEUKEMIA LYMPHOMA. 50, 4, p. 612-618 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Pathophysiology of gastrointestinal acute graft-versus-host disease and the potential role of glucagon-like peptide 2

    Zeiser, R., Chen, Y-B., Youssef, N. N. & Ayuk, F., 05.2023, In: BRIT J HAEMATOL. 201, 4, p. 620-627 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  11. Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study

    Schubert, M-L., Bethge, W. A., Ayuk, F. A., von Bonin, M., Vucinic, V., Wagner-Drouet, E. M., Subklewe, M., Baldus, C. D., Glass, B., Marks, R., Mougiakakos, D., Schroers, R., Stelljes, M., Topp, M. S., Wulf, G., Kröger, N., Dreger, P., German Lymphoma Alliance (GLA) & German National Registry for Stem Cell Transplants (DRST), 24.10.2023, In: BLOOD ADV. 7, 20, p. 6191-6195 5 p.

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  12. Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.

    Oyekunle, A., Zander, A. R., Binder, M., Ayuketang, F. A., Zabelina, T., Christopeit, M., Stübig, T., Alchalby, H., Schafhausen, P., Lellek, H., Wolschke, C., Müller, I., Bacher, U. & Kröger, N-M., 2013, In: ANN HEMATOL. 92, 4, p. 487-496 10 p., 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Outcome after Transplantation According to Reduced-Intensity Conditioning Regimen in Patients Undergoing Transplantation for Myelofibrosis

    Robin, M., Porcher, R., Wolschke, C., Sicre de Fontbrune, F., Alchalby, H., Christopeit, M., Cassinat, B., Zabelina, T., Peffault de Latour, R., Ayuketang, F. A., Socié, G. & Kröger, N., 07.2016, In: BIOL BLOOD MARROW TR. 22, 7, p. 1206-11 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report

    Pidala, J., Kitko, C., Lee, S. J., Carpenter, P., Cuvelier, G. D. E., Holtan, S., Flowers, M. E., Cutler, C., Jagasia, M., Gooley, T., Palmer, J., Randolph, T., Levine, J. E., Ayuk, F., Dignan, F., Schoemans, H., Tkaczyk, E., Farhadfar, N., Lawitschka, A., Schultz, K. R., Martin, P. J., Sarantopoulos, S., Inamoto, Y., Socie, G., Wolff, D., Blazar, B., Greinix, H., Paczesny, S., Pavletic, S. & Hill, G., 08.2021, In: TRANSPL CELL THER. 27, 8, p. 632-641 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies

    Schriewer, L., Schütze, K., Petry, K., Hambach, J., Fumey, W., Koenigsdorf, J., Baum, N., Menzel, S., Rissiek, B., Riecken, K., Fehse, B., Röckendorf, J. L., Schmid, J., Albrecht, B., Pinnschmidt, H., Ayuk, F., Kröger, N., Binder, M., Schuch, G., Hansen, T., Haag, F., Adam, G., Koch-Nolte, F. & Bannas, P., 2020, In: THERANOSTICS. 10, 6, p. 2645-2658 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM).

    Kröger, N-M., Einsele, H., Wolff, D., Casper, J., Freund, M., Derigs, G., Wandt, H., Schäfer-Eckart, K., Wittkowsky, G., Schmitz, N., Krüger, W., Zabelina, T., Renges, H., Ayuketang Ayuk, F., Krüll, A. & Zander, A., 2003, In: BONE MARROW TRANSPL. 31, 11, p. 973-979 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Monocenter study on epidemiology, outcomes, and risk factors of infections in recipients of 166 allogeneic stem cell transplantations during 1 year

    Samek, M., Iversen, K., Belmar Campos, C., Berneking, L., Langebrake, C., Wolschke, C., Ayuk, F., Kröger, N. & Christopeit, M., 08.2020, In: EUR J HAEMATOL. 105, 2, p. 126-137 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.

    Mösbauer, U., Ayuketang Ayuk, F., Schieder, H., Lioznov, M., Zander, A. R. & Kröger, N., 2007, In: HAEMATOLOGICA. 92, 2, p. 275-276 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor-T cell therapy

    Berger, S. C., Fehse, B., Akyüz, N., Geffken, M., Wolschke, C., Janson, D., Gagelmann, N., Luther, M., Wichmann, D., Frenzel, C., Thayssen, G., Alegiani, A., Badbaran, A., Zeschke, S., Dierlamm, J., Kröger, N. & Ayuk, F. A., 01.02.2023, In: HAEMATOLOGICA. 108, 2, p. 444-456 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Minimal residual disease diagnostics in patients with acute myeloid leukemia in the post-transplant period: comparison of peripheral blood and bone marrow analysis.

    Stahl, T., Badbaran, A., Kröger, N., Klyuchnikov, E., Zabelina, T., Zeschke, S., Schafhausen, P., Schultz, W., Asenova, S., Smirnova, A., Wolschke, C., Ayuketang Ayuk, F., Zander, A. R., Fehse, B. & Bacher, U., 01.10.2010, In: LEUKEMIA LYMPHOMA. 51, 10, p. 1837-1843 7 p., 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Management of Cytokine Release Syndrome (CRS) and HLH

    Ayuketang, F. A. & Jäger, U., 2022, The EBMT/EHA CAR-T Cell Handbook. Kröger, N., Gribben, J., Chabannon, C., Yakoub-Agha, I. & Einsele, H. (eds.). 1 ed. Cham: Springer International Publishing, p. 135-139 5 p.

    Research output: SCORING: Contribution to book/anthology › Chapter › Research

  22. Major central nervous system complications after allogeneic stem cell transplantation: a large retrospective study on 888 consecutive adult patients

    Mannina, D., Berneking, L., Both, A., Timm, W., Urbanowicz, T., Wolschke, C., Ayuk, F. A., Fischer, N., Fiehler, J., Grzyska, U., Rösner, S., Choe, C-U., Kröger, N. & Christopeit, M., 12.2020, In: EUR J HAEMATOL. 105, 6, p. 722-730 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Magnetic resonance enterography for assessment of intestinal graft-versus-host disease after allogeneic stem cell transplantation

    Derlin, T., Laqmani, A., Veldhoen, S., Apostolova, I., Ayuketang, F. A., Adam, G., Kröger, N. & Bannas, P., 05.2015, In: EUR RADIOL. 25, 5, p. 1229-1237

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. MAGIC biomarkers predict long term outcomes for steroid-resistant acute GVHD

    Major-Monfried, H., Renteria, A. S., Pawarode, A., Reddy, P., Ayuk, F., Holler, E., Efebera, Y. A., Hogan, W. J., Wölfl, M., Qayed, M., Hexner, E. O., Wudhikarn, K., Ordemann, R., Young, R., Shah, J., Hartwell, M. J., Chaudhry, M., Aziz, M., Etra, A., Yanik, G. A., Kröger, N., Weber, D., Chen, Y-B., Nakamura, R., Rösler, W., Kitko, C. L., Harris, A. C., Pulsipher, M., Reshef, R., Kowalyk, S., Morales, G., Torres, I., Özbek, U., Ferrara, J. L. M. & Levine, J. E., 21.06.2018, In: BLOOD. 131, 25, p. 2846-2855 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation.

    Kröger, N., Binder, T., Zabelina, T., Wolschke, C., Schieder, H., Renges, H., Ayuketang Ayuk, F., Dahlke, J., Eiermann, T. & Zander, A. R., 2006, In: TRANSPLANTATION. 82, 8, p. 1024-1030 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.

    Kröger, N-M., Shimoni, A., Zagrivnaja, M., Ayuketang Ayuk, F., Lioznov, M., Schieder, H., Renges, H-H., Fehse, B., Zabelina, T., Nagler, A. & Zander, A., 2004, In: BLOOD. 104, 10, p. 3361-3363 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation Analysis

    Derigs, P., Bethge, W. A., Krämer, I., Holtick, U., von Tresckow, B., Ayuk, F., Penack, O., Vucinic, V., von Bonin, M., Baldus, C., Mougiakakos, D., Wulf, G., Schnetzke, U., Stelljes, M., Fante, M., Schroers, R., Kroeger, N., Dreger, P., German Lymphoma Alliance (GLA) & German National Registry for Stem Cell Transplants (DRST), 12.2023, In: TRANSPL CELL THER. 29, 12, p. 750-756 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.

    Kröger, N., Zabelina, T., Renges, H., Krüger, W., Kordes, U., Rischewski, J., Schrum, J., Horstmann, M., Ayuketang Ayuk, F., Erttmann, R., Kabisch, H. & Zander, A. R., 2002, In: ANN HEMATOL. 81, 11, p. 627-631 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

    Lioznov, M., El-Cheikh, J., Hoffmann, F., Hildebrandt, Y., Ayuketang Ayuk, F., Wolschke, C., Atanackovic, D., Schilling, G., Badbaran, A., Bacher, U., Fehse, B., Zander, A. R., Blaise, D., Mohty, M. & Kröger, N., 2009, In: BONE MARROW TRANSPL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Late acute graft versus host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors

    Holtan, S. G., Khera, N., Levine, J. E., Chai, X., Storer, B., Liu, H. D., Inamoto, Y., Chen, G. L., Mayer, S., Arora, M., Palmer, J., Flowers, M. E. D., Cutler, C. S., Lukez, A., Arai, S., Lazaryan, A., Newell, L. F., Krupski, C., Jagasia, M. H., Pusic, I., Wood, W., Renteria, A. S., Yanik, G., Hogan, W. J., Hexner, E., Ayuketang, F. A., Holler, E., Watanaboonyongcharoen, P., Efebera, Y. A., Ferrara, J. L. M., Panoskaltsis-Mortari, A., Weisdorf, D., Lee, S. J. & Pidala, J., 10.2016, In: BLOOD. 128, 19, p. 2350-2358

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Langzeitnachsorge von Patienten nach allogener Blutstammzelltransplantation

    Ayuketang, F. A. & Kroger, N., 2018, Langzeitnachsorge von Patienten nach allogener Blutstammzelltransplantation. Ayuk, F., Kröger, N. & Tichelli, A. (eds.). 1. ed. Uni-Med

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  32. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.

    Kröger, N., Zagrivnaja, M., Schwartz, S., Badbaran, A., Zabelina, T., Lioznov, M., Ayuketang Ayuk, F., Zander, A. R. & Fehse, B., 2006, In: EXP HEMATOL. 34, 5, p. 688-694 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

    Stübig, T., Alchalby, H., Ditschkowski, M., Wolf, D., Wulf, G., Zabelina, T., Wolschke, C., Ayuketang, F. A. & Kröger, N., 01.08.2014, In: LEUKEMIA. 28, 8, p. 1736-8 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

    Kröger, N., Alchalby, H., Klyuchnikov, E., Badbaran, A., Hildebrandt, Y., Ayuketang Ayuk, F., Bacher, U., Bock, O., Kvasnicka, M., Fehse, B. & Zander, A. R., 2009, In: BLOOD. 113, 8, p. 1866-1868 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Iron Chelation with Deferasirox Suppresses the Appearance of Labile Plasma Iron During Conditioning Chemotherapy Prior to Allogeneic Stem Cell Transplantation

    Essmann, S., Heestermans, M., Dadkhah, A., Janson, D., Wolschke, C., Ayuk, F., Kröger, N. M. & Langebrake, C., 01.2023, In: TRANSPL CELL THER. 29, 1, p. 42.e1-42.e6

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Iron Chelation with Deferasirox increases Busulfan AUC during Conditioning Chemotherapy prior to Allogeneic Stem Cell Transplantation

    Essmann, S., Dadkhah, A., Janson, D., Wolschke, C., Ayuk, F., Kröger, N. M. & Langebrake, C., 02.2022, In: TRANSPL CELL THER. 28, 2, p. 115.e1-115.e5

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors.

    Kröger, N., Zabelina, T., Krüger, W., Renges, H., Stute, N., Rischewski, J., Sonnenberg, S., Ayuk, F., Ayuketang Ayuk, F., Schade, U., Fiegel, H., Erttmann, R., Löliger, C. & Zander, A. R., 2002, In: BONE MARROW TRANSPL. 29, 8, p. 683-689 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

    Harris, A. C., Young, R., Devine, S., Hogan, W. J., Ayuketang, F. A., Bunworasate, U., Chanswangphuwana, C., Efebera, Y. A., Holler, E., Litzow, M., Ordemann, R., Qayed, M., Renteria, A. S., Reshef, R., Wölfl, M., Chen, Y-B., Goldstein, S., Jagasia, M., Locatelli, F., Mielke, S., Porter, D., Schechter, T., Shekhovtsova, Z., Ferrara, J. L. M. & Levine, J. E., 01.2016, In: BIOL BLOOD MARROW TR. 22, 1, p. 4-10 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors.

    Neth, O. W., Bacher, U., Das, P., Zabelina, T., Kabisch, H., Kroeger, N., Ayuketang, F. A., Lioznov, M., Waschke, O., Fehse, B., Thiébaut, R., Haston, R. M., Klein, N. & Zander, A. R., 01.01.2010, In: BONE MARROW TRANSPL. 45, 1, p. 13-9 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Individualized busulfan dosing improves outcomes compared to fixed-dose administration in pre-transplant minimal residual disease-positive acute myeloid leukemia patients with intermediate-risk undergoing allogeneic stem cell transplantation in CR

    Klyuchnikov, E., Langebrake, C., Badbaran, A., Dadkhah, A., Massoud, R., Freiberger, P., Ayuk, F., Janson, D., Wolschke, C., Bacher, U. & Kröger, N., 02.2023, In: EUR J HAEMATOL. 110, 2, p. 188-197 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

    Akahoshi, Y., Spyrou, N., Hogan, W. J., Ayuk, F., DeFilipp, Z., Weber, D., Choe, H. K., Hexner, E. O., Rösler, W., Etra, A. M., Sandhu, K., Yanik, G. A., Chanswangphuwana, C., Kitko, C. L., Reshef, R., Kraus, S., Wölfl, M., Eder, M., Bertrand, H., Qayed, M., Merli, P., Grupp, S. A., Aguayo-Hiraldo, P., Schechter, T., Ullrich, E., Baez, J., Beheshti, R., Gleich, S., Kowalyk, S., Morales, G., Young, R., Kwon, D., Nakamura, R., Levine, J. E., Ferrara, J. L. M. & Chen, Y-B., 22.08.2023, In: BLOOD ADV. 7, 16, p. 4479-4491 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis

    Alchalby, H., Yunus, D-R., Zabelina, T., Ayuketang, F. A. & Kröger, N-M., 09.2016, In: BONE MARROW TRANSPL. 51, 9, p. 1223-7 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Incidence and Outcome of Late Relapse after Allogeneic Stem Cell Transplantation for Myelofibrosis

    Atagunduz, I. K., Christopeit, M., Ayuk, F., Zeck, G., Wolschke, C. & Kröger, N., 12.2020, In: BIOL BLOOD MARROW TR. 26, 12, p. 2279-2284 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis

    Shahnaz Syed Abd Kadir, S., Christopeit, M., Wulf, G., Wagner, E., Bornhauser, M., Schroeder, T., Crysandt, M., Mayer, K., Jonas, J., Stelljes, M., Badbaran, A., Ayuketang Ayuk, F., Triviai, I., Wolf, D., Wolschke, C. & Kröger, N., 09.2018, In: EUR J HAEMATOL. 101, 3, p. 305-317 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Impact of physiological BM CD10+CD19+ B-cell precursors (haematogones) in the post-transplant period in patients with AML

    Christopeit, M., Heiland, A., Binder, M., Zabelina, T., Ayuketang, F. A., Horn, C., Haferlach, T., Bokemeyer, C., Kröger, N. & Bacher, U., 01.09.2013, In: BONE MARROW TRANSPL. 48, 9, p. 1257-9 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  46. Impact of molecular residual disease post allografting in myelofibrosis patients

    Wolschke, C., Badbaran, A., Zabelina, T., Christopeit, M., Ayuketang, F. A., Triviai, I., Zander, A., Alchalby, H., Bacher, U., Fehse, B. & Kröger, N-M., 11.2017, In: BONE MARROW TRANSPL. 52, 11, p. 1526-1529

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation

    Kröger, N., Panagiota, V., Badbaran, A., Zabelina, T., Triviai, I., Araujo Cruz, M. M., Shahswar, R., Ayuketang, F. A., Gehlhaar, M., Wolschke, C., Bollin, R., Walter, C., Dugas, M., Wiehlmann, L., Lehmann, U., Koenecke, C., Chaturvedi, A., Alchalby, H., Stadler, M., Eder, M., Christopeit, M., Göhring, G., Koenigsmann, M., Schlegelberger, B., Kreipe, H-H., Ganser, A., Stocking, C., Fehse, B., Thol, F. & Heuser, M., 07.2017, In: BIOL BLOOD MARROW TR. 23, 7, p. 1095-1101

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT

    Forcade, E., Chevret, S., Finke, J., Ehninger, G., Ayuk, F., Beelen, D., Koster, L., Ganser, A., Volin, L., Sengeloev, H., Michallet, M., Tischer, J., Jindra, P., Cascon, M. J. P., Koc, Y., Arat, M., Tomaszewska, A., Hayden, P., de Witte, T., Yakoub-Agha, I., Kröger, N. & Robin, M., 05.2022, In: BONE MARROW TRANSPL. 57, 5, p. 768-774 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients

    Gagelmann, N., Ayuk, F. A., Klyuchnikov, E., Wolschke, C., Berger, S. C. & Kröger, N., 01.10.2023, In: HAEMATOLOGICA. 108, 10, p. 2799-2802 4 p.

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  50. Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.

    Kröger, N-M., Badbaran, A., Zabelina, T., Ayuketang, F. A., Wolschke, C., Alchalby, H., Klyuchnikov, E., Atanackovic, D., Schilling, G., Hansen, T., Schwarz, S., Heinzelmann, M., Zeschke, S., Bacher, U., Stübig, T., Fehse, B. & Zander, A. R., 2013, In: BIOL BLOOD MARROW TR. 19, 3, p. 398-404 7 p., 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 5 Next